Symbol Lookup

Saturday April 30, 2016 9:05 AM ET. Data delayed 15 minutes.
2.86
-0.31 (-9.78%)
Bid/Lots
2.86/0
Ask/Lots
2.87/0
Open/Prev Close
3.18/3.17
Day Range
2.83-3.18
52-Week Range
2.83-28.50
Vol/Avg Daily Vol
57.0K/130.4K
  • TSX Comp
  • TSX Venture
  • DJIA
  • S&P 500
  • NASDAQ
Price Comparison Chart
Data delayed at least 15 minutes.

Recent News»

0 New Today
CombiMatrix Corporation to Release 2016 First Quarter Financial Results on May 4, 2016
6:00AM ET on Wednesday Apr 27, 2016 by GlobeNewswire

CombiMatrix Corporation (NASDAQ:CBMX) announces that it will release financial results for the three months ended March 31, 2016 after market close on Wednesday, May 4, 2016. CombiMatrix management will hold an investment community conference ...

CombiMatrix Notes Two Additional Blue Cross Blue Shield Health Plans Revise Medical Policies to Reimburse for Recurrent Pregnancy Loss Testing
6:00AM ET on Tuesday Apr 26, 2016 by GlobeNewswire

CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for pre-implantation genetic diagnostics and screening, miscarriage analysis, prenatal and pediatric diagnostics, notes that Blue ...

Midday Update: Wall Street Feeling Pressure From Declining Oil, Mixed Earnings, Economic Data
12:57PM ET on Thursday Apr 21, 2016 by MT Newswires
12:57 PM EDT, 04/21/2016 (MT Newswires) -- Wall Street has been struggling to extend its current winning streak to a fourth day, with stocks declining Thursday following renewed pressure on oil futures prices and mixed economic data that failed t...
CombiMatrix Shares Rise 14%; Reviews Strategic Alternatives
9:02AM ET on Thursday Apr 21, 2016 by MT Newswires
09:02 AM EDT, 04/21/2016 (MT Newswires) -- CombiMatrix (CBMX) shares were higher 14% in recent pre-market trade after the molecular diagnostics company said it has begun to explore strategic options, including mergers and acquisitions. "Armed wit...
BRIEF-Combimatrix says begun exploring strategic options, including M&A
6:06AM ET on Thursday Apr 21, 2016 by Thomson Reuters

April 21 (Reuters) - Combimatrix Corp

* Combimatrix provides strategic update

* Begun to explore strategic options including a range of potential M&A an...

Company Information

CombiMatrix Corporation is a provider of molecular diagnostic solutions. The Company specializes in pre-implantation genetic screening, miscarriage analysis, prenatal diagnosis and pediatric developmental disorders, offering deoxyribonucleic acid-based testing for the detection of genetic abnormalities, which cannot be identified through traditional methodologies. It performs genetic testing utilizing a range of cytogenomic techniques, including chromosomal microarray analysis, fluorescence in situ hybridization and karyotyping. Its prenatal and postnatal microarray focuses on diagnosing genomic syndromes associated with intellectual disability, developmental delays, congenital anomalies, dysmorphic features and autism spectrum disorders. It develops and markets its molecular testing services in approximately four markets, such as in vitro fertilization (IVF), miscarriage analysis (products of conception analysis), prenatal genetics and postnatal developmental disorders.

CONTACT INFORMATION

Headquarters310 Goddard Ste 150
IRVINE, CA, United States 92618-4617
Phone949-753-0624
Fax949-753-1504

EXECUTIVE OFFICERS

Chairman of the Board, President, Chief Executive OfficerRobert Jessup
DirectorMark McDonough
Chief Financial Officer, Treasurer, SecretaryScott Burell
Independent DirectorScott Gottlieb
Independent DirectorRobert Hoffman

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Stocks Ratings Sample

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

  •  
  • INK Company Insider

    Detailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®

  • S&P Capital IQ Stock Report

    S&P Capital IQ's analysts' overview and valuation, with key fundamental, quantitative, and technical analysis.

  • TDSI Morning Action Notes

    Morning Institutional Report of company updates and new recommendations.

Market Cap$3.0MBeta0.19
Revenue (TTM)$10.1MEPS$-9.30
Shares Out.1.1MBook Value$6.93
Dividend Yield0.00%P/E--
Annual Dividend Rate0.00 USDPrice/Sales (TTM)0.3
Ex-Div Date1/1/01P/Cash Flow (TTM)--
Pay Date1/1/01Operating Margin-64.81%

*GAAP = prior to non-GAAP analyst adjusted earnings.

(Non-GAAP)*

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Stocks Calendar Sample